Mangal Credit and Fincorp Limited moves to reshape its capital structure

Issue price: Rs 247 per warrant, comprising Rs 10 face value and Rs 237 premium. The filing does not state the numeric SEBI-mandated floor price, so the premium or discount to that floor cannot be calculated from the disclosed terms. It is therefore not possible to conclude whether Rs 247 was above, equal to, or below the floor price based on this filing alone. ^[1]

Fully diluted equity impact: Each warrant carries the right to subscribe to one equity share. If all 2,500,000 warrants are converted, the company’s fully diluted equity base will increase by 2,500,000 shares. ^[2]

The resulting calculation is:

• Post-conversion fully diluted shares = existing issued shares + 2,500,000
• Dilution to pre-issue shareholders = 2,500,000 / post-conversion fully diluted shares

The percentage dilution and final fully diluted share count cannot be quantified because the pre-issue issued equity base is not stated in the warrant-allotment disclosure. The warrants have an 18-month validity period from allotment, so the dilution is contingent on conversion rather than immediate equity dilution. ^[3]

The 2,500,000 warrants were allotted to six investors: five promoter allottees received 2,400,000 warrants in total, while one non-promoter allottee received 100,000 warrants ^[4].

Shareholding after 100% conversion

Assuming every warrant is converted into one equity share, total shares would increase from 21,113,986 to 23,613,986. The pre-issue promoter holding was 11,665,847 shares, or 55.25% ^[5].

The calculation is derived from the 24 lakh promoter and 1 lakh non-promoter warrant allocation, the pre-issue promoter share count, and the current equity base. The 59.99% promoter figure shown in the earlier proposal assumed that all 25 lakh warrants would be converted by the promoter group ^[5]; it does not reflect the final allotment, which includes 100,000 warrants issued to a non-promoter. Conversion is not automatic: the warrants have an 18-month validity period, with the balance consideration payable on exercise ^[4].

Mangal’s 18-month warrant tenure is shorter than its recent debt-raising tenors of 21 months to up to 27 months, while the financing burden is materially different: the warrant issue has no coupon and requires only 25% upfront, whereas the company’s NCDs carried an 11.75% annual coupon. The Rs 247 warrant price cannot be judged as a premium or discount to market because the relevant allotment-date share price, VWAP and valuation reference are not reported in the cited material.

Terms comparison

The Rs 247 price consists of Rs 10 face value and Rs 237 premium ^[1]. That premium is only a premium to face value; it does not establish that the warrants were issued above or below the prevailing market price. A meaningful pricing comparison would require the allotment-date market price and the SEBI Chapter V pricing calculation.

Comparison with Mangal’s previous funding

Mangal’s May 2026 board proposal for up to 2.5 million fully convertible warrants did not specify a numerical issue price; it stated that the price would be determined under Chapter V of the SEBI ICDR Regulations ^[5]. The October allotment therefore represents the crystallisation of that earlier proposal at Rs 247, with an 18-month validity period.

The more relevant completed funding comparison is debt. The company’s disclosed 2026 NCD terms were 11.75% p.a., against an 18-month warrant period ^{[6] [3]}. However, these are not directly comparable prices:

• The NCD investor receives a contractual coupon and principal repayment and the instruments are secured, rated, listed and redeemable ^[6].
• The warrant holder receives no coupon; the company initially receives only 25% of the headline consideration, with the remaining capital dependent on exercise within the 18-month period ^{[1] [8]}.
• The warrant issue is therefore cheaper for Mangal in immediate cash-servicing terms, but it carries potential equity dilution rather than a fixed interest obligation.

The headline Rs 61.75 Crores should consequently not be treated as cash already received in full. The immediately paid amount is Rs 15.44 Crores; the balance is payable on conversion ^{[1] [8]}.

Peer read

The only directly comparable preferential warrant structure in the cited material is Sammaan Capital’s Tranche II issue, which also used an 18-month exercise period ^[7]. That supports the view that 18 months is a conventional, rather than unusually long, warrant tenure. Its Rs 139 issue price cannot be compared mechanically with Mangal’s Rs 247 because the two companies have different share prices, capital structures and valuation bases.

For U. Y. Fincorp, CSL Finance, Purple Finance, Niyogin Fintech and Sera Investments, no specific preferential warrant issue price and tenure are reported in the cited material. They therefore cannot support a quantified small-cap NBFC peer benchmark here.

Interest-rate interpretation

The contemporaneous 11.75% NCD coupon is the clearest company-specific funding benchmark, but it does not establish whether Mangal’s warrant pricing is attractive or aggressive in the broader interest-rate environment. No dated RBI policy rate, government-bond benchmark, or comparable small-cap NBFC NCD yield is reported alongside the warrant issue.

The practical distinction is clearer than the valuation conclusion: Mangal has raised a portion of capital through a shorter-duration, non-coupon instrument with only 25% immediate funding, rather than relying solely on debt at an 11.75% coupon. The issue is also heavily promoter-backed: five promoter allottees received 24 lakh of the 25 lakh warrants, or 96% of the issue, based on the allotment table ^[1]. That supports funding commitment, but makes the Rs 247 price a less clean arm’s-length institutional price-discovery benchmark.